2016
DOI: 10.1186/s12968-016-0316-4
|View full text |Cite
|
Sign up to set email alerts
|

The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study

Abstract: BackgroundNo unified method exists to effectively predict and monitor progression of pulmonary arterial hypertension (PAH). We assessed the longitudinal relationship between a novel marker of cardiopulmonary reserve and established prognostic surrogate markers in patients with pulmonary vascular disease.Methods and ResultsTwenty participants with confirmed (n = 14) or at high risk (n = 6) for PAH underwent cardiovascular magnetic resonance (CMR) at baseline and after ~6 months of guideline-appropriate manageme… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…As a result, there continues to be a need to focus on cost-effective medicine with avoidance of repetitive and redundant testing. CMR has often been recognized as a cost-effective/comprehensive test for evaluation and prognosis in myocarditis with T2 mapping [54], pulmonary vascular disease [55], implantable cardiodefibrillators (ICD) [56], and amyloidosis [57]. 2018 publications in this area included:…”
Section: Outcomes/prognosismentioning
confidence: 99%
“…As a result, there continues to be a need to focus on cost-effective medicine with avoidance of repetitive and redundant testing. CMR has often been recognized as a cost-effective/comprehensive test for evaluation and prognosis in myocarditis with T2 mapping [54], pulmonary vascular disease [55], implantable cardiodefibrillators (ICD) [56], and amyloidosis [57]. 2018 publications in this area included:…”
Section: Outcomes/prognosismentioning
confidence: 99%
“…In this study of 20 patients with pulmonary artery hypertension who underwent CMR at baseline and at 6 months of guideline-appropriate management, Baillie et al [42] performed phase-contrast CMR of mean pulmonary artery blood flow velocity at rest and during continuous infusion of adenosine. Changes in the CMR parameters during the 6 months correlated with functional and biochemical changes.…”
Section: Introductionmentioning
confidence: 99%
“…Cardiovascular magnetic resonance (CMR) is accurate and reproducible in the assessment of cardiac size, morphology, and function and allows noninvasive assessment of blood flow. [3][4][5] Recently, time-resolved phase contrastedmagnetic resonance imaging (MRI) with velocity encoding along all 3 flow directions and 3-dimensional anatomic coverage (also termed "4-dimensional [4D] flow MRI"), provides unrivaled capabilities for comprehensive analysis of complex blood flow patterns using new visualization tools. 6,7 Pulmonary arterial wall shear stress, blood flow, pulse-wave velocities, and kinetic energy losses also have been noninvasively evaluated with 4D flow MRI.…”
mentioning
confidence: 99%